Alkaloid posts €263 million in sales and €17.3 million investments in Jan–Sep 2026
Consolidated sales reached 16,205,440,429 denars (+7%); investments in fixed assets were 1,067,280 thousand denars (+34%), and exports rose sharply in Kazakhstan and Switzerland.
Alkaloid AD Skopje recorded consolidated sales of €263 million, investments of €17.3 million and 60 new jobs in North Macedonia in the January–September 2026 period.
On a single-entity basis, sales for January–September reached 10,358,253,210 denars, a 2% increase compared with the same period last year. Consolidated sales amounted to 16,205,440,429 denars, representing a 7% rise year-on-year.
Markets, product mix and export performance
Consolidated domestic sales climbed by 13% versus the previous year; 37% of total consolidated sales were generated on the domestic market and 63% abroad. By region, Southeast Europe accounted for 28% of consolidated sales, Eastern Europe 18%, and Western Europe 17%.
The strongest export growth compared with last year was seen in Kazakhstan, where sales grew 3.3 times, and in Switzerland, where they increased 2.6 times. Looking at product groups, pharmaceuticals made up 92% of total consolidated sales, while chemistry, cosmetics and herbal products accounted for 8%.
Total consolidated investments in fixed assets in January–September 2026 amounted to 1,067,280 thousand denars, an increase of 34% compared with the same period of the previous year. Single-entity EBITDA was 2,724,714,506 denars, up about 7%, while single-entity net profit was 1,636,713,332 denars, also up 7%. Consolidated EBITDA reached 2,990,429,419 denars, a growth of 8%, and consolidated net profit was 1,544,111,223 denars, up 4%.
During January–September 2026, Alkaloid AD Skopje recorded 60 new hires in North Macedonia. The company’s shares have been traded on the Macedonian Stock Exchange since 2002 and are among the most actively traded and liquid. The share price between January and September ranged from 21,745.00 to 27,300.00 denars, with an average of 24,398.08 denars per share.
Alkaloid’s business plan for 2026 foresees investing around 8% of consolidated sales revenue into tangible and intangible assets, a 7% increase in consolidated sales compared with 2025, and a 7% rise in consolidated profit versus 2025.
Photo: press material from the event
